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This paper reviews the many criticisms of the publication by Seralini et al (2012) which has led to so much
controversy, was retracted and then republished in this journal. Seralini et al found that a GM maize and its
associated herbicide Roundup resulted in numerous chronic abnormalities in rats. The vehemence of the critics is
not matched by their evidence; it is often based on entrenched assumptions and on mis-representing published
material. The arguments have challenged normal healthy scientific dialogue, and appear to be driven by other
motives. A further interpretation of Seralini et al's results on tumour formation is suggested. The probability that
Seralini et al's results are significant is sufficient to justify further study.Background
Genetically modified organisms (GMOs) in agriculture
have been controversial from the start. The debate fre-
quently reaches beyond scientific/technical issues and
demonstrates the poor state of scientific dialogue and
public understanding [1]. The arguments have again be-
come acute following the publication by Seralini et al.
[2] which reported that a herbicide resistant GM maize
and the associated herbicide Roundup each led to long-
term chronic disease in rats including early formation of
tumours. This paper was a challenge to GM interests
and provoked immediate and widespread criticism and
press coverage [3]. The speed of response was such that
one could question whether this was disinterested scien-
tific exchange [4]. The editor of the journal finally
retracted the paper because, after much discussion, it
was considered insufficiently definitive: “Ultimately, the
results presented (while not incorrect) are inconclu-
sive….” [5]. Inconclusive results are not usually sufficient
reason for retraction. Inconclusiveness would indeed
apply to the initial publications of many or even most of
the great discoveries in biology, as the author of [4] has
pointed out. The controversies continue.Correspondence: uel@ednet.co.uk
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provided the original work is properly creditedThe Seralini et al. paper was republished in this jour-
nal [6] with responses by Seralini to the critics; how-
ever, the critics’ publications have not been retracted
and remained in the historical record. Heinemann [4]
defended Seralini et al.’s paper long before it was
retracted, and Meyer and Hillbeck [7] demonstrated
how the criticism by the European Food Safety Authority
(EFSA) suffered from double standards. Following these, I
question here whether there exists sufficient substantive
evidence given by critics (other than EFSA) to deny the
validity of Seralini et al.’s findings. I refer here to the ori-
ginal Seralini et al. (2012) article and not to its re-
publication, which has been edited with changed figure
and table numbers.
The criticism of Seralini et al. was so vehement in
condemnation that it threatened (and ultimately pre-
vented) normal scientific discourse. I examine the val-
idity of the critical arguments and the assumptions
behind them and how the conduct of this controversy
reflects on the integrity of science. In the process, I
suggest some further interpretations of the Seralini
et al. paper. There is a documented history of antagon-
ism towards papers that demonstrate negative effects of
GM crops [8]. It is important to study the rationale be-
hind such antagonism.distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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Seralini et al.’s experimental design followed closely that
of earlier work by others, with which it is compared in
Table 1 of their paper. The major purpose was to extend
the trials from the accepted protocol of 90 days to over
700 days, because some evidence of disease was already
apparent after only 90 days.
In outline, Sprague Dawley (SD) rats, 8 weeks old,
were randomly assigned into 10 groups of 10 for each
sex (200 animals in total) and fed with rat chow sup-
plemented with three proportions of the GM maize
NK603, grown with or without Roundup (R). Control
groups were fed with rat chow supplemented with the
non-transgenic maize as control. The drinking water
for three further groups was supplemented with three
concentrations of Roundup, the lowest being below
the permitted standards for drinking water, and a con-
trol. The rats were monitored twice weekly through-
out, and blood samples were taken 11 times during
the 750 days of the experiment. Body weight and food
consumption were monitored but not reported. The
health of these rats through life is described in figures,
tables and photographs. An important difference from
previous trials, and especially from Monsanto’s trial
given in their application for approval (released by the
European Food Safety Authority in 2013), was the lat-
ter’s use of some non-isogenic maize in control feeds.
When the experimental rats showed effects that were
within the spread of these controls, it was “concluded
that this difference was not biologically meaningful.”
In this way, small effects up to 90 days were ignored.
To the authors’ surprise many treated rats, especially
females, developed tumours after a year, while the con-
trols developed fewer tumours and later. The numerous
effects on liver, kidney and pituitary functions were ex-
pected from the authors’ previous data.
Sources of the criticisms of the Seralini et al. paper
The widespread condemnation of the Seralini et al.
paper was publicised via three routes:
1. The Science Media Centre was quick to publicise
many comments online [9]. Publication was so fastTable 1 The ratios of tumour days in GMO-treated female rats to co
Figure 2 by summing numbers of tumours appearing over 25-day per
is approached in the last 100 days, showing numerically what can be s
become less significant, as described in the text
Days Ratio tumour days treated/contr
100 to 550 3.04
100 to 650 2.38
550 to 650 1.92
650 to 750 1.23that some critics had very little time to study the
paper adequately;
2. About 17 letters to the editor of Food and Chemical
Toxicology (FCT) criticised the paper and asked for
its retraction [10];
3. A fuller paper of criticism appeared later (Arjo et al.
[11]), and an informative report was published by The
Flemish Interuniversity Institute for Biotechnology
(Vlaams Interuniversitair Instituut voor Biotechnologie)
(VIB) [12], (quoted by [13] in the submission to FCT);
the European Food Safety Authority compiled similar
materials [14] which were the subject of critique by
Meyer and Hillbeck [7]. Seralini et al. reply to other
parts of Arjo et al.’s arguments, in their republished
paper in this journal [6].
Main Text
General criticisms
Most comments included general accusations about the
quality of the work, such as:
“The study appeared to sweep aside all known
benchmarks of scientific good practice and, more
importantly, to ignore the minimal standards of
scientific and ethical conduct…” (Arjo et al. [11]), and
“Throughout their manuscript, Séralini et al. ignore
clear indications that there is something
fundamentally wrong in their experimental design”
(Grunewald [13]).
Such judgments were widespread. Does the evidence
justify them?
Many challenged the study design for not following
OECD or EPA protocols for safety testing for tumours.
The experiments, however, were not safety tests. A
safety test requires a large enough trial not to miss a rare
occurrence. No one would be satisfied by a safety test
with only 10 animals. These particular OECD and EPA
protocols are therefore not relevant. It must also be
stressed that differences in experimental protocol do not
necessarily imply that one or another is flawed, as Meyer
and Hillbeck [7] pointed out.ntrols over different time periods, taken from Seralini et al.’s
iods. A ratio of 1 would indicate no difference from control; this
een in the figure, at which time the experimental findings
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key flaw in the paper is the poor study design, which
is based on the discredited hypothesis that inserting a
gene into the genome of a crop species is inherently
more likely to produce unintended, unexpected and
hazardous characteristics than would be the case
using conventional breeding.”
There are several different fundamental errors in this
statement, which assumes that an inserted gene can have
no adverse action other than the intended action. This is
a commonly held assumption and is related to the
concept of “substantial equivalence”, but it is factually
wrong; the hypothesis in the quote is not discredited by
the majority of scientists. This is considered more fully
in the “Discussion” section.
A multiplicity of errors
The critics point out a diversity of errors within the
Seralini et al. paper. The VIB report concludes with a
bullet-pointed list of identified errors including the
following:
“There is no mention of how the nutritional balance
was kept in the various diets. If you replace 22 or
33 % of the food with maize, you change the
percentage or the amount of carbohydrates, protein,
fats, fiber, vitamins and so on, in the diet.”
“There is no indication whatsoever of whether the
genetically modified maize originating from the land
that was sprayed with Roundup contained traces of
the degradation products of Roundup and, if so, how
much there was, and how this compared to the
amount of Roundup that was fed to all the animals”.
Arjo et al. listed “many major critical errors” in their
Table 3. For example, under the heading “False or un-
substantiated statements”, they and others give several
instances of inadequate reporting of results and of tests
that were made. They claim that there is insufficient de-
tail about the feed materials; as in the VIB quote above,
and by Wager [15]:
“a robust experiment would also include a random,
unrelated diet, e.g., one derived from organic maize)…..
Critical details on how much food was consumed by
each rat are absent, making it impossible to establish
any dose/response relationship.”
These comments fail to appreciate that all diets, in-
cluding the controls, were equally balanced with 33 %
maize (GM or not); sources and details of the feed mate-
rials are described by Seralini et al., but more detailwould have been useful. The GM maize grown with
Roundup was as in usual agricultural practice, and maize
was tested for contaminating pesticides. It is correct that
total feed intake and rat weights were not reported, but
they were monitored. Again, more data would be useful.
A common complaint was that neither the concentra-
tion and stability of glyphosate in the drinking water nor
the amounts consumed by rats were given: Roundup
was given ad lib at stated concentrations. Since ad lib
provision represents a realistic regime, as it would be for
farm animals and for humans, the amounts consumed
by rats are not relevant. The use of Roundup is consid-
ered separately below.
Many complained that “Control data [was] not always
included in the limited cases where data are presented
to support the conclusions”. With few exceptions, this is
incorrect. All tables and figures other than the photo-
graphs of rats with tumours (Figure 3, Seralini et al.) in-
clude the relevant control data; (note that the important
Figure 2 is ignored by all, as described below).
The above are typical examples of criticism that arises
from misreading or misunderstanding the paper and se-
lection of mostly minor or irrelevant matters. In many
cases, further information would indeed have enriched
the paper and might have been provided in a supple-
mentary paper online.
I conclude that these critical comments could have
been addressed in a workshop presentation of the results
and most complaints could be answered by provision of
more data. None are sufficient, however, to invalidate
the data and results of Seralini et al.
Most critics comment on the number of deaths in
control and experimental groups, for example pointing
out that male rats that were given Roundup at the high-
est concentration actually lived a little longer than the
controls. All of these comments, although quoting from
Seralini et al.’s Figure 1 which gives the time course of oc-
currence of deaths, deal mainly with the totals of deaths at
the end of the experiment. This, notably, is the fault in
Arjo et al.’s Table 1 [11] which by not mentioning the tim-
ing is a misrepresentation. Similarly, the VIB paper [12]
quotes only the final end-of-experiment histograms from
Figure 1, omitting the timing. While it does seem extraor-
dinary that at the highest doses of Roundup male rats live
a few days longer than controls, no significance can be at-
tached to such small differences. (It is just conceivable that
the highest concentration of Roundup offers some pro-
tection, in a non-monotonic manner; see [16].) Since
Seralini et al. themselves draw no essential conclusions
from Figure 1, the matter does not justify further concern.
The incidence of tumours
Figure 2 in Seralini et al. shows that treated rats ac-
quired tumours earlier than did the controls. It was
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that became the subject of widespread concern, media
coverage and controversy. The two most frequent and
substantive criticisms of the paper were that the num-
bers of rats were too small with too few controls and that
Sprague Dawley (SD) rats suffer spontaneous tumours
anyway, making the conclusions of Seralini et al. meaning-
less. EFSA, for example, states: [14] “….the observed fre-
quency of tumours is influenced by the natural occurence
of tumours typical of this strain, regardless of any treat-
ment. This is neither taken into account nor discussed in
the Séralini et al. (2012) publication.”
Yet most of the critics in the several communications
cited above never mention Seralini et al.’s Figure 2 and
do not discuss or criticise its findings. One critic who
did mention Figure 2 [17] complained: “There are other
confusing sentences that also reflect poor editorial work,
for example “Up to 14 months, no animals in the control
groups showed any signs of tumors whilst 10–30 % of
treated females per group developed tumors, with the
exception of one group (33 % GMO+ R).”….I was left
wondering if anyone had really read the paper carefully.”
Careful reading shows that the quoted sentence is fact-
ually correct. Another also found the paper difficult to
interpret [18] and questioned whether control rats got
tumours because of the absence of photographs of con-
trol tumours. This critic concluded: “Numerically, we
cannot tell, because they are absent also from Figure 2.”
Every section of Figure 2, however, shows a control
curve. The critic’s error could be a misreading, perhaps
the result of the too rapid reply required by the Science
Media Centre (the same critic also misread Table 2,
which included the 10 controls, not fewer; the wording
here is clear but can be misread) VIB, [12] without men-
tion or quote from Figure 2 concludes: “Only once you
have increased the size of the groups significantly will
the chances that you have divided the animals incor-
rectly drop considerably. This is the second fundamental
flaw in the research design used by Séralini et al. They
use far too few animals per treated group.”Their criti-
cism is considered further below under “Statistical
issues” section.
Since Figure 2 is of core importance for the whole
paper, I offer my interpretation as follows:
Simple inspection of Figure 2 shows that the curves of
appearance of tumours in treated rats rise ahead of those
representing the control tumours. Incidence of tumours
in control rats are generally consistent with the pub-
lished literature (such as the five references quoted by
Arjo et al., see below) and serve to check against unfore-
seen local anomalies. It is important to note that there is
considerable variation in the literature about the inci-
dence of tumours in control SD rats. Many studies
concluding that GM materials are safe have used suchvariable historical controls. The variation serves to in-
crease the background “noise” and this tends to hide
small indications of disease, as reviewed in [19] and ex-
plored by Meyer and Hillbeck [7].
As rats age and their pathology increases, so the differ-
ence between treated and control rats decreases; in other
words, the signal-to-noise ratio of experimental to control
reduces. Yet most critics considered only the incidence of
tumours at the end of the experiments, that is, when the
signal-to-noise ratio must have become low. For example,
1 of the 17 critics in [10] showed ingeniously that the
figures for tumour incidence in Seralini et al.’s Table 2
looked like random numbers. The figures he quoted, how-
ever, were also end-of-experiment data. Nevertheless, the
total of pathologies in the treated animals remained always
greater than in the controls even this Table 2. Critics
(including VIB) fail to discuss the timing of appearance of tu-
mours in Figure 2. It is the timing of appearance of tumours
that, to me, is significant and should not be overlooked.
In Figure 2, the tumour incidence in treated and con-
trol rats can be seen as the areas enclosed between the
respective curves and the x-axis for any chosen time
period. The units for these areas can be defined as “ac-
cumulated tumour days”. These can be easily summed
from the graphs in Figure 2 in order to put tangible figures
to otherwise intuitive visualisation. One can then express
the results as the ratio of “tumour days” in treated rats to
“tumour days” in control rats for any specified period. For
example, I added the tumour days in Figure 2 “FEMALES
GMO” (top right) by summing together the tumours as
they appeared under all three feeding doses of 11, 22, and
33 % GMO (divided by 3 to apply per 10 rats) neglecting
any differences between doses. In this way, 30 treated rats
are compared to 10 controls. The ratios of tumour days of
treated to control rats are shown in Table 1.
The change in the ratio with time provides a measure
of internal control. In this example, during the period of
100–650 days, there are nearly 2 ½ times as many
tumour days in the treated rats as in the control rats,
while in the last 100 of these (550–650 days), the ratio is
only 1.92. This suggests that significant results are lim-
ited to about 550 days. No statistical analysis could deny
that the large ratio of 3.04 up to 550 days is significant.
However, results presented in this way could be sub-
jected to serious errors at the early stages when very few
tumours occur. For this reason, the total numbers of
tumour days are indicated. (see also the VIB criticism
under the “Statistical issues” section below.)
One can also express the results as time of appearance
of the first five tumours per 10 rats (i.e., 50 % occur-
rence). This is 710 days for controls, 470 to 630 for
GMO treated and 470 to 530 for Roundup treated. This
provides a convenient way to summarise the findings,
akin to an “LD50”.
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clusions that the treated rats developed tumours signifi-
cantly sooner than did the control rats. The results are
also consistent with the critics’ arguments and with the
literature, which shows that SD rats get tumours anyway,
but only later in life.
I conclude that, contrary to the criticisms, SD rats are
the appropriate animal for these experiments precisely
because of their susceptibility to late tumorogenesis, in
agreement with Meyer and Hillbeck [7]. This idea is
taken further in the “Discussion” section.
In summary, Figure 2, which with its accompanying
photographs gave rise to the most publicity (yet has been
the most ignored by all the critics), acts as the crucial
and informative data about the onset of tumours. The
figure shows clearly that there is an effect by a GM crop
as well as by its associated herbicide. There is no reason
to extrapolate these findings, however, beyond the ex-
perimental results. The conclusions of Seralini et al.
need not apply to other GM systems, as seems to have
been assumed by many anti-GMO interests, as well as
by most of the critics.
Statistical issues
Among the many criticisms about the statistics used,
VIB elegantly describe the possible errors from using
too few controls: “The chances that we will have
made groups of 10 among the females in which in the
one instance two and in the other instance nine
animals will spontaneously develop tumors, or four
and eight instead of six, are extremely good” “This is a
fundamental error in the research design: there are
too few control groups in relation to the treated
groups.”
It is of course possible that of the 10 groups of 20 rats
(10 for each sex) tested, 1 group has a lower incidence of
spontaneous tumours than the rest. Such a group would
be an outlier in the distribution. An outlier like this could
happen to be chosen by the researchers as a control. The
probability of a whole group of 10 rats showing a lower in-
cidence of tumours is low, and there is a 1 in 10 probabil-
ity that such a group would be chosen as control. In this
unlikely case, Seralini et al.’s conclusions would indeed be
rendered invalid. This argument seems to answer: “…how,
in such a long-term experiment, can you differentiate be-
tween tumors that occur spontaneously from those that
occur as a consequence of eating genetically modified
maize, or drinking Roundup.”
The analysis I give probably answers the above by con-
sidering the time course of appearance of tumours. Neg-
lect of the timing of tumour appearance was a universal
error of the critics.Seralini et al.’s Figure 5 shows the SEMs of the numer-
ous parameters measured at 15 months, (450 days) ar-
ranged in order from the highest increase to the highest
decrease of a parameter, over control values. It would be
difficult to argue that these are without significance. Any
experimental biologist, searching for effects and finding
results such as Seralini et al. did in Figures 2 and 5,
would assume that they had found something suffi-
ciently meaningful to justify further experimentation.
Imagine that if the experiments had given the opposite
results and showed that the onset of tumours was
delayed by the treatments, the same critics may have
(sceptically) accepted those findings as hints towards
finding ways to delay human tumourogenesis!
More animals and statistical analysis might have
allowed one to determine a greater or lesser degree of
confidence; but certainty was not claimed by Seralini
et al. and nor was it required, since theirs was not a test
for safety. The results in the (largely ignored) Figure 2
leave us with the likelihood that the effects are real and
the probability that they are of significance.
Scientific common sense must be the initial way to as-
sess this experimental data; statistical analysis follows
when needed, but usually it is better to repeat the ex-
periment with appropriate improvements. In this case,
with hindsight, two sets of 10 control rats would have
enhanced the evidence. Meanwhile, Seralini et al.’s re-
sults remain significant, even if the level of confidence is
below 95 %.
Roundup and glyphosate
There was much criticism that glyphosate
concentrations and levels of its consumption were not
given by the researchers and that only a whole
formulation of Roundup was described and used. Arjo
et al. took this further suggesting that Seralini et al.
“justify the use of commercial formulations rather
than the pure active ingredient on the tenuous basis
that environmental exposure is to the whole product.
The weakness of this argument is apparent from the
differing behavior of formulations and their
ingredients in terms of environmental stability,
mobility in ground water, …” [11].
Roundup is the commercial material being tested; one
cannot know a priori whether any toxicity is due to gly-
phosate or an adjuvant or to their combined actions. This
is a common error that assumes that because glyphosate is
the active herbicide principle it is also the material to be
tested for other activities; this puts assumption before ex-
periment. There are many reports about the toxicity of
glyphosate itself (e.g., [19, 20] and of its untoward effects
on the microbial community in soils [21].
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response relationship, for example: “…highest incidence
of tumors supposedly found in the animals administered
the lowest dose. These conclusions are not only implaus-
ible, but they are entirely discordant with the body of lit-
erature already available for glyphosate.” [11]. However,
there is a growing body of literature about damage
caused by glyphosate, such as [20] quoted above; also,
non-monotonic dose-response curves are common in
biology [16].
I conclude that the criticisms about the use of
Roundup by Seralini et al. were not relevant to the ex-
periment, which was concerned with the material used
in agricultural practice, not with glyphosate itself.The 90-day protocol
The conventional 90-day test period has become the
norm, and most deny the need for longer term experi-
ments: Arjo et al. defend the 90-day protocol thus:
“This particular rat strain exhibits a 45–80 % inci-
dence of spontaneous tumors in the absence of any
exogenous factor, depending on the diet and whether
or not fed ad libitum (Prejean et al. 1973; Davis et al.
1956; Keenan et al. 1996; Suzuki et al. 1979; Thompson
et al. 1961). The rats normally begin developing these
spontaneous tumors after 90 days, and are used in
shorter-term experiments to ascertain
tumorigenicity,....”
None of the above references given in the Arjo et al.
paper anywhere mention 90 days, and none of them give
a time scale for the appearance of tumours. Each states,
however, that rats develop tumours only in older age,
such as “540 days” (Davis et al. and Prejean et al.) or
older than “18 months” (Suzucki et al.) and, with a com-
plex chow formulation, “in female rats ranging in age
from 11 to 30 months (21.78 average)” (Thompson et al.);
Keenan et al. report tumour incidence later in life, re-
duced under a restricted diet, a similar finding to the
older one of Davis.
One has to conclude that the above quoted paragraph
is erroneous reporting of all five references. The case for
longer term experiments remains. One might note that
the protocol of 90 days became the norm after it was set
arbitrarily by Monsanto in its applications and has been
since adopted by others without question or any appar-
ent justification.Conclusions from the critical evidence
The criticisms described above contain several serious
flaws and omissions, such as the following: Misreporting (e.g., of the five references and their
association with 90-day trials);
 Misunderstanding (e.g., the omission of Figure 2 and
the distortion of the use of Roundup);
 Unwarranted assumptions (e.g., putting presumption
before experiment, such as expecting a dose-
response effect and the discrediting a common
hypothesis (see below);
 Misreading of data, especially regarding
experimental controls (e.g., complaints that there
were none in critical places).
The criticisms also included useful comments, such as
the dearth of detailed information on food consumption
and rats’ weights; these were measured by Seralini et al.
but not reported and could have been provided online as
supplementary information.
However, as illustrated with the examples given, I could
not find any substantive material definitive enough to in-
validate the paper. The most substantial and repeated crit-
icisms were either false or could be answered easily. We
are left, predominantly, with polemical criticisms that fail
scientifically.
This is an unsatisfactory situation for the interests of bio-
technologists in gene transfer (GMOs) as well as for any
deeper understanding of the issues among biologists and
the public. It is worthwhile, therefore, to examine under-
lying modes of thought that led to such vehement denial.
Discussion
However, improbable they may seem, Seralini et al.’s re-
sults indicate that the GM system has caused disease in
the rats and that the causal agent(s) is not a macro
change in the feed but a micro unknown non-visible
change. Such a change would escape notice in analyses
that search for unintended changes in metabolic mate-
rials, as described by Herman and Price [22] in their plea
that: “suspect unintended compositional effects that
could be caused by genetic modification have not mate-
rialized on the basis of this substantial literature. Hence,
compositional equivalence studies uniquely required for
GM crops may no longer be justified on the basis of sci-
entific uncertainty”.
If, then, the crucial changes in the GM crop are micro
and more like hormonal ones as Seralini et al. suggest, it
also follows that the experiment can be a difficult one to
confirm depending, as it must, on unknown small effects.
What underlies the criticisms of Seralini et al.?
Arjo et al. claim (as quoted above) that the hypothesis of
damage from inserted genes is discredited. The evidence
for this claim is clear: that the methods of gene transfer
are a success, that the crop plant does have the charac-
teristics intended, and that GM crops are grown and
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properties. This also supports the basic principles of
genetics on which the GM technology is based. Arjo
et al.’s claim seems to be shared implicitly by most or all
of the critics of the Seralini et al. paper. It seems, how-
ever, that problems begin to appear only when searches
for other and unintended effects become more thorough
and extended, as in Seralini et al.’s paper. There is now
growing evidence that the claim is false, with the follow-
ing implications:
1. Arjo et al.’s accusation of “bad design” due to the
“discredited” hypothesis is false, because the
hypothesis that inserted genes may produce
unwanted effects is a finding, not a presumption.
That the accusation is false is also underlined by the
internationally binding legislation of the UN
Cartagena Protocol on Biosafety of 2000 carried
forward in 2014 and representing the minimum
consensus of over 160 signatory nations.
2. Of all the assertions made this one most requires
supporting references despite its widespread
acceptance, but none are given nor are they in
similar criticisms by other critics, except for the
repeated references to other long-term trials that
showed no harmful effects.
3. Many studies show that inserted genes do exert
multiple effects, reviewed in [23]. The basics of gene
structure and function lead one to expect this. Thus,
a) most genes are pleiotropic, exerting unknown
diversities of functions; b) many proteins themselves
have multiple activities, including control functions;
c) most “junk” DNA is transcribed (as emphasised by
ENCODE), and the RNA has complex multiple
control functions; d) as a result, a randomly inserted
gene is likely to hit some function; e) the transferred
gene, with a strong promoter added and introns
removed, may have activities other than those
intended. (Much of this was apparent 14 years ago [1].)
4. Therefore, the idea that inserted genes exert no
unintended damaging effects is an implicit
hypothesis which has become an assumption and is
now entrenched as a consensus. This consensus
cannot be applied as criticism of Seralini et al.’s
paper merely because it indicated the opposite of
those many other results.
5. This consensus also allows the continued misuse of
the ill-defined term “GMO”, leading for example, to
the frequent claims that “Genetic Modification” is
merely a form of speeded up breeding carried out
ever since agriculture began. Maybe this is intended
to allay public fears by showing how the process is
ordinary, occurs in nature and is nothing new,
(gene modification is after all the basis of evolution).Thereby, the new and exciting developments of gene
transfer methods become buried from view, rather
than being extolled. Public understanding of science
is therefore betrayed and this stance becomes
counter-productive.
There are so many such instances of accepted philoso-
phies or dogmatic assumptions in the history of science
that the geneticist Waddington, who introduced the idea
of epigenetics, coined the acronym COWDUNG (COn-
ventional Wisdom of the DominaNt GroUp), [24]. Those
who have worked on or tried to publish findings that
run contrary to a prevailing consensus have been con-
demned or ignored and suffered years of opposition,
even if proved to be ultimately correct (for example, re-
call Peter Mitchell’s long struggle to combine the (at the
time almost opposed) fields of structural cell biology of
membranes with the biochemistry of soluble enzymes to
create his chemiosmotic hypothesis, now the accepted
mechanism of how mitochondria and chloroplasts work;
or the years of disbelief in Howard Temin’s evidence for
“reverse” transcription because at the time the Central
Dogma of molecular biology was simplistically held to
mean that information can flow only one way from DNA
to RNA; even now we still call them “retroviruses”). These
two examples are of healthy (if over-severe) scepticism
which resisted the challenges to conventional perceptions.
In these cases, increasing evidence over time led to new
understanding.
But scientists who have published provocative results
about GM crops have been vilified beyond any scientific
justification [8], as seems to be the case here. Seralini
et al. challenged the dominant consensus. Following this
case, Carrasco [20] was also attacked, even beyond his
death. In contrast to my two examples above, such atti-
tudes of vilification undermine and ultimately prevent
scientific progress.
The rat tumours
Seralini et al.’s results deserve closer scrutiny. There ap-
pears to be a subtle influence of diet, which is already
hinted at in other literature as cited above. One can
compare the situation with that in humans, who are
similarly prone to tumours with increasing age and in
whom tumourogenesis is certainly hastened by known
and unknown influences (as indicated by the incidences
of cancer in different countries). For humans, no one de-
nies the need for long-term studies; the rat 90-day trial
could be compared with a tobacco smoking trial in hu-
man teenagers which is stopped in their 20s, long before
lung cancer becomes apparent.
As many critics have pointed out, however, after
more than 10 years of GMO crops, there are no signs
of disease in animals or humans that can be ascribed to
Loening Environmental Sciences Europe  (2015) 27:13 Page 8 of 9GM technology. Seralini’s answer to this is obvious:
that farm animals do not live long enough [25]; to
which one can add that humans live too long and that
there has not been time enough for major problems to
develop. There is, however, evidence that some harm is
becoming apparent. Among these is the opening para-
graph of Keenan et al.’s paper (quoted by Arjo et al. in
connection with the 90-day test, see above) which
points out that “Laboratory rat survival in 2-year car-
cinogenicity studies has been declining over the past
three decades.” This is re-iterated later [26]. Similarly, a
farming report [27] lamented the increase in develop-
mental abnormalities and abortion in cattle, threaten-
ing the industry over three decades. The report blamed
oestrogen-like pollution. There have been many anec-
dotal reports from several countries of new abnormal-
ities appearing on farms in recent years, especially
following the introduction of Roundup for weed-
management. Teratogenic effects of Roundup have
been reported in vertebrates [20] and reviewed in [19].
Early reports predate the use of GM crops, but
Roundup and other herbicides have a longer history of
widespread use.
Thompson et al.’s (1961) experiments (quoted in
Arjo et al.) involved complex diets which could be the
reason for the large temporal spread of onset of tu-
mours (11–30 months). Perhaps they are a presage to
Seralini et al. indicating that some features of rat chow
can lead to abnormalities in sensitive animals. It
should be noted that when tumour development is re-
ferred to as “spontaneous” this denotes ignorance of
cause rather than lack of cause. One may therefore be
able to find conditions in which SD rats develop fewer
tumours than in normal laboratory controls. Given the
probability that Seralini et al.’s findings have some val-
idity, it would be worthwhile to try an “inverted” re-
peat of their experiments, in which improved diets are
compared to “normal” controls, such as a trial with
SD rats kept under semiwild conditions on an organic
farm. The UK Government’s National Health Service
recommendation to consume “Five a Day” of fruit and
vegetables is an uncontrolled trial of this sort, with
one of the assumed benefits being a reduced incidence
of cancer (although this is not at all proven).Conclusion
The scientific/technological attitude
How is it that many distinguished gene transfer scientists
have condemned Seralini et al. so vehemently on such a
weak basis? The simplest answer is that theirs was such a
bad paper but then why the vehemence? I have to con-
clude that long and deep engagement in the science of
gene transfer (usually but incorrectly named “GMO”, asexplained above) and safety testing has resulted in a blindly
accepted consensus among a circle of gene engineering in-
terests that makes any contradictory findings unacceptable.
One is justified in asking as in [4] whether the criticism
was motivated by something other than science, some con-
scious or unconscious imperative to defend the current
COWDUNG (which is supported, one may note, by large
corporate interests as also are the deniers of human-
caused climate warming). A lack of consensus among sci-
entists in general about the safety of GMOs was published
in this journal while this paper was being written [28].
Had the criticisms been worthy of rigorous scientific
dialogue, useful progress could have resulted. For ex-
ample, if one can identify a difference between insertion
of a DNA cassette and insertions due to recombination
in meiosis or insertions of transposons, then one might
discover new features about the mechanisms and control
of gene action. But the effect of the criticisms was to “si-
lence” the discussion and to inhibit the scientific enquiry
that Seralini et al. had initiated.
If a GM crop threatens a potential problem, then the
response should be to check that problem and then fix
it. Responsible further study might lead to new discover-
ies. As it is a far from resolving antagonism towards
GMOs, the critics have fostered mistrust among both
the public and among many biologists. Their efforts will
be counter-productive for the further development of
the subject. The matter has now become so polarised
that it threatens the rationality of further debate, just at
a time when gene transfer methods are becoming more
sophisticated.
One can now question whether and how the present
gene transfer technologies should be further applied to
agriculture. Thus, Arjo et al. write (perhaps surprisingly):
“New findings that affect entrenched opinions and
economic interests have their detractors, particularly
those with a potential global impact. One of the key
ethical principles of science states that “not all that can
be done must be done” (Institut Borja de Bioètica 2012).
Science itself is neutral, but individual scientists and their
supporters inevitably have particular interests....” [29]
Precisely so, the great successes of applied molecular
biology have led to their own shared and self-
reinforced certainties, a COWDUNG or “Pie in the
Sky” [30]. Much of modern science has indeed been
applied on the basis of “I can, therefore I do” [31].
The “plurality of opinion” about GMOs may be due
to the differing attitudes about scientific progress
and its applications. A re-think is in order.
Seralini et al. [25] note that their paper was “a first
step in the iterative investigation of the long-term
health effects on mammals of these commercial
products that should be replicated independently, as
Loening Environmental Sciences Europe  (2015) 27:13 Page 9 of 9well as on developing mammals”. Their paper has to
stand or fall through further experiment over time,
but the criticisms reported above can only hinder
progress and remain an indictment of the quality of
the underlying scientific discourse.
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